Files

562698.pdf (400.41 KB)

Document type

Article

Version

Published version

Publication date

1992

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/22431

Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1136/ard.51.2.160

Abstract

The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work.

Subject

Lupus eritematós, Síndrome antifosfolipídica, Estudi de casos

Subject (English)

Lupus erythematosus, Antiphospholipid syndrome, Case studies

Citation

Collections

Articles publicats en revistes (Medicina)

Citation

VIANNA, Joao L., et al. Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 1992. Vol. 51, num. 2, pags. 160-161. ISSN 0003-4967. [consulted: 18 of June of 2026]. Available at: https://hdl.handle.net/2445/22431

Export metadata

JSON - METS

Share record